Paper40242585
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma.
Pk L and 3 others. ACS Pharmacol Transl Sci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma. Papers, record 40242585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40242585
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References229
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19445926 | The prostanoid EP(2) receptor agonist ONO-AE1-259-01 protects against glutamate-induced neurotoxicity in rat retina. | Eur J Pharmacol | 2009 | https://conductscience.org/library/papers/19445926 | PubMed |
| 2 | 19005073 | Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. | J Neurosci | 2008 | https://conductscience.org/library/papers/19005073 | PubMed |
| 3 | 12356827 | Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. | Invest Ophthalmol Vis Sci | 2002 | https://conductscience.org/library/papers/12356827 | PubMed |
| 4 | 32690657 | Long Noncoding RNA AW112010 Promotes the Differentiation of Inflammatory T Cells by Suppressing IL-10 Expression through Histone Demethylation. | J Immunol | 2020 | https://conductscience.org/library/papers/32690657 | PubMed |
| 5 | 37490970 | The Role of Gut Microbiota in Glaucoma Progression and Other Retinal Diseases. | Am J Pathol | 2023 | https://conductscience.org/library/papers/37490970 | PubMed |
| 6 | 28730968 | Modulation of the Immune System for the Treatment of Glaucoma. | Curr Neuropharmacol | 2018 | https://conductscience.org/library/papers/28730968 | PubMed |
| 7 | 35884791 | The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases. | Biomedicines | 2022 | https://conductscience.org/library/papers/35884791 | PubMed |
| 8 | 19403821 | Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. | J Neurosci | 2009 | https://conductscience.org/library/papers/19403821 | PubMed |
| 9 | 30096952 | Effect of Heat-Killed Lactobacillus paracasei KW3110 Ingestion on Ocular Disorders Caused by Visual Display Terminal (VDT) Loads: A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study. | Nutrients | 2018 | https://conductscience.org/library/papers/30096952 | PubMed |
| 10 | 23009741 | Ocular perfusion pressure and ocular blood flow in glaucoma. | Curr Opin Pharmacol | 2013 | https://conductscience.org/library/papers/23009741 | PubMed |
| 11 | 18299320 | Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18299320 | PubMed |
| 12 | 25470070 | Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols. | J Med Chem | 2015 | https://conductscience.org/library/papers/25470070 | PubMed |
| 13 | 29775216 | Neuroinflammation and microglia in glaucoma: time for a paradigm shift. | J Neurosci Res | 2019 | https://conductscience.org/library/papers/29775216 | PubMed |
| 14 | 8600890 | Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. | Arch Ophthalmol | 1996 | https://conductscience.org/library/papers/8600890 | PubMed |
| 15 | 32673372 | Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/32673372 | PubMed |
| 16 | 24427137 | Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. | Front Pharmacol | 2014 | https://conductscience.org/library/papers/24427137 | PubMed |
| 17 | 17401376 | Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. | Nat Med | 2007 | https://conductscience.org/library/papers/17401376 | PubMed |
| 18 | 25876735 | Effects of Cannabinoids on T-cell Function and Resistance to Infection. | J Neuroimmune Pharmacol | 2015 | https://conductscience.org/library/papers/25876735 | PubMed |
| 19 | 14757702 | Cannabinoids and neuroinflammation. | Br J Pharmacol | 2004 | https://conductscience.org/library/papers/14757702 | PubMed |
| 20 | 29500424 | Systemic inflammation induced by lipopolysaccharide aggravates inherited retinal dystrophy. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29500424 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41243046 | An assessment of the prevalence of cannabis use in eye clinic patients and its implications on glaucoma diagnosis and management. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/41243046 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40242585
GET https://conductscience.org/api/papers/v1/40242585/references?page=2